Jump to content

General anaesthetic: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
→‎Lipid theory: making it even more clear that this mechanism is old, and counter to current understanding
→‎Ion channels: Bringing this more inline with what is taught to me in medical school, and a more recent paper than what was previously cited. This is still not very good, and someone with more knowledge of the field should revise it.
Line 29: Line 29:


===Ion channels===
===Ion channels===
General anaesthetics exert their action by the activation of inhibitory [[central nervous system]] (CNS) receptors, and the inactivation of CNS excitatory receptors. The relative roles of different receptors is still under much debate, but evidence has emerged for some targets being involved with particular anaesthetics.
General anaesthetics inhibit excitatory functions of some [[central nervous system]] (CNS) receptors, such as neuronal nACh,<ref name="Weber_nAChR_anaesthetics">{{cite journal |author=Weber M, Motin L, Gaul S, Beker F, Fink RH, Adams DJ |title=Intravenous anaesthetics inhibit nicotinic acetylcholine receptor-mediated currents and Ca2+ transients in rat intracardiac ganglion neurons |journal=Br. J. Pharmacol. |volume=144 |issue=1 |pages=98–107 |year=2005 |month=January |pmid=15644873 |pmc=1575970 |doi=10.1038/sj.bjp.0705942 }}</ref> glutamate, or 5-HT3 receptors. Some general anaesthetics also excite inhibitory receptors, notably GABA<sub>A</sub> receptors and TREK. GABA<sub>A</sub> is a major target of the IV anaesthetics [[thiopental]] and [[propofol]].


Multiple anaesthetics have been found to affect the inhibitory GABA-A receptor, including [[propofol]], [[thiopental]] and [[isoflurane]]. However, xenon and nitrous oxide are thought to have no effect here. Glycine receptors have been suggested as putative target for at least the analgesic effect of inhalational anaesthetics.
General anaesthetics may decrease transmitter release presynaptically or decrease excitability of postsynaptic neuron.

2-pore-domain potassium channels, with the subfamilies TREK and TASK, have recently emerged as a potential target. These channels regulate membrane excitability, and halothane has been found to reduce neuronal firing by hyperpolarizing neurons by a current similar to TASK. Knockout mouse models have provided support for TREK-1. NMDA receptors, HCN channels and some sodium channels
<ref name="Franks_Molecular_targets_underlying_general_anaesthesia">{{cite journal |author=Franks NP |title=Molecular Targets Underlying General Anaesthesia |journal=Br. J. Pharmacol. |volume=147 |issue=1 |pages=72-81 |year=2006 |month=January |pmid=15644873 |pmc=16402123 |doi=10.1038/sj.bjp.0706441 }}


==Pharmacokinetics==
==Pharmacokinetics==

Revision as of 04:47, 7 September 2012

A general anaesthetic (or anesthetic, see spelling differences) is a drug that brings about a reversible loss of consciousness. These drugs are generally administered by an anaesthesia provider to induce or maintain general anaesthesia to facilitate surgery. The biological mechanism(s) of the action of general anaesthetics are not well understood.

Mode of administration

Drugs given to induce or maintain general anaesthesia can be either as gases or vapours (inhalational anaesthetics), or as injections (intravenous anaesthetics or even intramuscular). It is possible to deliver anaesthesia solely by inhalation or injection, but most commonly the two forms are combined, with an injection given to induce anaesthesia and a gas used to maintain it.

Inhalation

Inhalational anaesthetic substances are either volatile liquids or gases, and are usually delivered using an anaesthesia machine. An anaesthesia machine allows composing a mixture of oxygen, anaesthetics and ambient air, delivering it to the patient and monitoring patient and machine parameters. Liquid anaesthetics are vapourized in the machine. All of these agents share the property of being quite hydrophobic (i.e., as liquids, they are not freely miscible in water, and as gases they dissolve in oils better than in water).

Many compounds have been used for inhalation anaesthesia, but only a few are still in widespread use. Desflurane, isoflurane and sevoflurane are the most widely used volatile anaesthetics today. They are often combined with nitrous oxide. Older, less popular, volatile anaesthetics, include halothane, enflurane, and methoxyflurane. Researchers are also actively exploring the use of xenon as an anaesthetic.

Injection

Injection anaesthetics are used for induction and maintenance of a state of unconsciousness. Anaesthetists prefer to use intravenous injections, as they are faster, generally less painful and more reliable than intramuscular or subcutaneous injections. Among the most widely used drugs are:

  • Propofol
  • Etomidate
  • Barbiturates such as methohexital and thiopentone/thiopental
  • Benzodiazepines such as midazolam
  • Ketamine is used in the UK as "field anaesthesia", for instance at a road traffic incidents or similar situations where an operation must be conducted at the scene or when there is not enough time to move to an operating room, while preferring other anesthetics where conditions allow their use. It is more frequently used in the operative setting in the US.

Method of Action

Lipid theory

It was postulated by Overton and Meyer that general anaesthetics exert their action by acting on the plasma membrane. This was supported by evidence that the potency of the drug has a direct, positive correlation with the lipid solubility of the blood.[1]

The mechanism of action was proposed to be increased fluidity of the membrane. The interpretation of the Overton and Meyer finding has been challenged and discredited.[2]

Ion channels

General anaesthetics exert their action by the activation of inhibitory central nervous system (CNS) receptors, and the inactivation of CNS excitatory receptors. The relative roles of different receptors is still under much debate, but evidence has emerged for some targets being involved with particular anaesthetics.

Multiple anaesthetics have been found to affect the inhibitory GABA-A receptor, including propofol, thiopental and isoflurane. However, xenon and nitrous oxide are thought to have no effect here. Glycine receptors have been suggested as putative target for at least the analgesic effect of inhalational anaesthetics.

2-pore-domain potassium channels, with the subfamilies TREK and TASK, have recently emerged as a potential target. These channels regulate membrane excitability, and halothane has been found to reduce neuronal firing by hyperpolarizing neurons by a current similar to TASK. Knockout mouse models have provided support for TREK-1. NMDA receptors, HCN channels and some sodium channels <ref name="Franks_Molecular_targets_underlying_general_anaesthesia">Franks NP (2006). "Molecular Targets Underlying General Anaesthesia". Br. J. Pharmacol. 147 (1): 72–81. doi:10.1038/sj.bjp.0706441. PMC 16402123. PMID 15644873. {{cite journal}}: Check |pmc= value (help); Unknown parameter |month= ignored (help)

Pharmacokinetics

Induction

Induction is between the onset of administration of anesthetic to surgical anesthesia. The speed of induction depends on the time taken for the drug to reach effective concentrations in the brain. IV anesthetic like Thiopental is generally used for induction.

Elimination

Volatile anaesthetics are eliminated in the terminal phase via the lungs. A low blood:gas partition coefficient is therefore necessary for quick removal of the anaesthetic. When the oil:water coefficient is high, there will be little anaesthetic in the blood, so elimination will be slow, giving a prolonged hangover effect.

Some drugs are metabolised by the liver, so consequently their metabolites are often toxic (e.g. chloroform).

See also

Notes

  1. ^ "Mechanism of action of inhaled anaesthetic agents". Anesthesia UK. 2005.
  2. ^ Ueda I (1999). "The window that is opened by optical isomers". Anesthesiology. 90 (1): 336. PMID 9915358. {{cite journal}}: Unknown parameter |month= ignored (help)

References

  • Rod Flower; Humphrey P. Rang; Maureen M. Dale; Ritter, James M. (2007). Rang & Dale's pharmacology (6th ed.). Edinburgh: Churchill Livingstone. ISBN 0-443-06911-5.{{cite book}}: CS1 maint: multiple names: authors list (link)